A Study to Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants
Clinical trial NCT02543268 · COMPLETED
Trial details
- NCT number
- NCT02543268
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-21
- Primary completion
- 2016-01-22
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.